Table 3.
Fluid Resuscitation (WG-5) | 14. Fluid resuscitation is essential unless part of the study | R |
15. Administer fluid resuscitation based on the specific requirements of the model | ||
16. Consider the specific sepsis model for the timing of the start and continuation for fluid resuscitation | ||
17. Resuscitation is recommended by the application of iso-osmolar crystalloid solutions | ||
g. Consider using pre-defined endpoints for fluid resuscitation as deemed necessary | C | |
h. Avoid fluid overload | ||
Antimicrobial Therapy (WG-6) | 18. Antimicrobials are recommended for pre-clinical studies assessing potential human therapeutics | R |
19. Antimicrobials should be chosen based on the model and likely/known pathogen | ||
20. Administration of antimicrobials should mimic clinical practice | ||
i. Antimicrobials should be initiated after sepsis is established | C |
R recommendation strength, C consideration strength